Clinical Trials Directory

Trials / Completed

CompletedNCT03219424

Predicting the Probability of Return To Work After Injury

Predicting the Probability of Return to Work After Injury in Hong Kong: Prospective Multicentre Cohort Study

Status
Completed
Phase
Study type
Observational
Enrollment
1,115 (actual)
Sponsor
Chinese University of Hong Kong · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

To evaluate return to work (RTW) status after moderate and major trauma in Hong Kong at one year after injury. To derive reliable prediction models for return to work.

Detailed description

Background: Trauma is a leading cause not only of death worldwide but also of disability, and in Hong Kong it ranks sixth as a cause of death for all age groups. The implementation of trauma systems has improved the survival of injured patients in many settings including Hong Kong. However, the aim of trauma care for the injured person is not only to prolong life but also to restore patients to the best possible health status, and where applicable, to return to work. Survivors of trauma often experience late sequelae that have a major impact on almost all aspects of everyday life, and improvements in functional outcome and health status may continue for at least five years post-injury. Objectives: 1. to evaluate return to work (RTW) status after moderate and major trauma in Hong Kong at one year after injury; 2. to derive reliable prediction models for RTW. Study design: This is a multi-centre, prospective long-term follow up cohort study of the 1163 trauma patients admitted to the Prince of Wales Hospital (PWH), Queen Elizabeth Hospital (QEH) and Tuen Mun Hospital (TMH) in Hong Kong in 2017-2018. Patients will be recruited within four weeks of ED attendance as soon as the patient is clinically stable and conscious. The follow-up period for return to work status of the 1163 trauma patients will extend from baseline to one year after trauma.

Conditions

Timeline

Start date
2017-09-01
Primary completion
2019-12-31
Completion
2022-02-28
First posted
2017-07-17
Last updated
2022-04-05

Locations

1 site across 1 country: Hong Kong

Source: ClinicalTrials.gov record NCT03219424. Inclusion in this directory is not an endorsement.